Cited by 21Carcinogens and Genotoxicity AssessmentAttention Deficit Hyperactivity DisorderGenomic variations and chromosomal abnormalities

Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate

Ponsa, Immaculada, Ramos-Quiroga, Josep Antoni, Ribasés, Marta, Bosch, Rosa, Bielsa, Anna, Ordeig, Maria Teresa, Morell, Marta, Miró, Rosa +6 more·2009·Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50% of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.] described the induction of chromosome abnormalities by MPH in children treated for three months, contrary to most of the in vitro and in vivo studies reported since then. We present new relevant information concerning the cytogenetic effects of MPH in children and adults. We include a prospective sample of 12 children and 7 adults with a new diagnosis of ADHD and naive to MPH. We analyzed the cytogenetic effects on peripheral lymphocytes before and three months after starting MPH therapy. The cytogenetic analyses included a cytokinesis-block micronucleus (CBMN) assay, a sister chromatid exchange (SCE) analysis and the determination of chromosome aberrations (CA). Following the same strategy and analyzing the same cytogenetic endpoints that were investigated in the original report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.], we found no evidence of increased frequency of micronuclei, sister chromatid exchanges or chromosome aberrations induced by MPH in children and adult populations. MPH treatment of children and adults with ADHD resulted in no significant genomic damage (as suggested by the three endpoints studied), results that do not support a potential increased risk of cancer after exposure to MPH.

Integrity signals

Registry

Crossref · 10.1016/j.mrfmmm.2009.03.014

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • No cytogenetic side-effects from stimulant use have been reported.

    “Likewise, no cytogenetic side-effects from stimulant use have been reported [60,61].”

    From Advances in understanding and treating ADHD (2011) · cites this paper as [60]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ponsa, I., Ramos-Quiroga, J. A., Ribasés, M., Bosch, R., Bielsa, A., Ordeig, M. T., Morell, M., Miró, R., de Cid, R., Estivill, X., Casas, M., Bayés, M., Cormand, B., & Hervás, A.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Vall d'Hebron Hospital Universitari (ES)
  • University Hospital Mútua de Terrassa (ES)
  • Universitat Pompeu Fabra (ES)
  • Instituto de Salud Carlos III (ES)
Venue
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Publisher
Elsevier BV
Published
2009-06
Volume
666
Issue
1-2
Pages
44-49
ISSN
  • 0027-5107 (ISSN-L)
  • 1386-1964
OpenAlex
W2149334606
Cited by
21
References
46
Citations by year
2025: 2 · 2018: 1 · 2014: 2 · 2013: 2 · 2012: 4
FWCI
1.56
Type
journal article
Language
en
Open access
closed
Locations
  • Mutation research. Fundamental and molecular mechanisms of mutagenesis (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (2005SGR00495, 2005SGR00848)
  • Instituto de Salud Carlos III (PI040524, PI041267, PI042010)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
methylphenidate, attention deficit hyperactivity disorder, cytogenetic effects, chromosomal abnormalities, micronuclei, sister chromatid exchange, peripheral blood lymphocytes, drug-induced genotoxicity, cancer risk, children, adults
MeSH terms
Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Chromosome Aberrations, Female, Humans, Male, Methylphenidate, Middle Aged, Sister Chromatid Exchange, Micronucleus Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review